Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacokinetics and Bioequivalence of 2 Azithromycin Tablet Formulations: A Randomized, Open‐Label, 2‐Stage Crossover Study in Healthy Volunteers.

Autor: Leong, Chuei Wuei¹ (AUTHOR) cwleong@duopharmabiotech.com, Yee, Kar Ming¹ (AUTHOR), Nalaiya, Jeyashanthini¹ (AUTHOR), Kassim, Zawahil¹ (AUTHOR), Rahim, Sharifah Radziah Syed Abd¹ (AUTHOR), Ahmad, Shahnun¹ (AUTHOR), Amran, Atiqah¹ (AUTHOR), Krishnamurthy, Lakshman² (AUTHOR)

Publikováno v: Clinical Pharmacology in Drug Development. Sep2022, Vol. 11 Issue 9, p1078-1083. 6p.

In Vitro Toxicity Evaluation of New Generic Latanost ^® and Latacom ^® as an Ophthalmic Formulation.

Autor: Ng JSC; Formulation R&D Technologies, Duopharma Innovation Sdn. Bhd., Shah Alam, Selangor, Malaysia., Tan YX; Formulation R&D Technologies, Duopharma Innovation Sdn. Bhd., Shah Alam, Selangor, Malaysia., Alwi NAA; Formulation R&D Technologies, Duopharma Innovation Sdn. Bhd., Shah Alam, Selangor, Malaysia., Yee KM; Formulation R&D Technologies, Duopharma Innovation Sdn. Bhd., Shah Alam, Selangor, Malaysia., Rashid AHA; Industrial Biotechnology Research Centre, SIRIM Berhad, Shah Alam, Selangor, Malaysia., Tan KL; Faculty of Medicine and Health Sciences, Universiti Sains Islam Malaysia (USIM), Persiaran Ilmu, Putra Nilai, Nilai, Negeri Sembilan, Malaysia., Leong CW; Formulation R&D Technologies, Duopharma Innovation Sdn. Bhd., Shah Alam, Selangor, Malaysia.

Publikováno v: Journal of current glaucoma practice [J Curr Glaucoma Pract] 2021 Sep-Dec; Vol. 15 (3), pp. 139-143.